Profil
Gunnar Kratz is the founder of Celltrix AB, founded in 2003, and Karocell Tissue Engineering AB, founded in 2001.
At Karocell Tissue Engineering AB, he held the title of Director from 2009 to 2010.
Dr. Kratz's former jobs include being a member at Medicarb AB, Mölnlycke Health Care Group AB, and MedCap AB.
Anciens postes connus de Gunnar Kratz
| Sociétés | Poste | Fin |
|---|---|---|
Karocell Tissue Engineering AB
 Karocell Tissue Engineering AB Miscellaneous Commercial ServicesCommercial Services Karocell Tissue Engineering AB was started in 2001 based on research from the Karolinska Institute since the end of the 1980's. It was founded by Professor Gunnar Kratz and Doctor Anders Boman to further develop their ideas within culturing of cells and tissue engineering. Tissue engineering, which is one of the fastest growing areas in medicine today, applies the principles of biology and engineering to the development of functional substitutes for damaged tissues. The objective is to have the engineered tissue to become integrated with the patient's own tissue. This can be achieved either by culturing cells in vitro for transplantation as an auto transplant or by guiding cells in vivo to regeneration. Karocell's core operations are; production of autologous cells, and management of a skin bank and a cell bank. | Fondateur | 29/12/2010 |
Celltrix AB
 Celltrix AB Medical SpecialtiesHealth Technology Celltrix AB manufactures medical devices. It develops novel and injectable dermal filler for reconstructive cosmetic surgery, based on microbeads of cross-linked gelatine. The company was founded in December 2003 by Kjell Gösta Conny Nilsson and is headquartered in Malmö, Sweden. | Fondateur | - |
| MEDCAP AB | Corporate Officer/Principal | - |
Mölnlycke Health Care Group AB
 Mölnlycke Health Care Group AB Medical SpecialtiesHealth Technology Mölnlycke Health Care manufactures and markets single-use surgical and wound care products. The firm's surgical division offers surgical solutions through a range of single-use products that help minimize the risk of infections for patients, protect healthcare workers and increase the efficiency in the operating room. Its brands include: BARRIER, Biogel and HiBi. The company is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - |
Medicarb AB
 Medicarb AB Pharmaceuticals: MajorHealth Technology Medicarb AB manufactures pharmaceutical products. It develops pharmaceuticals from biologically active carbohydrates and improves the performance of blood and tissue contacting medical devices with biocompatible coatings. The company was founded in 1983 and is headquartered in Bromma, Sweden. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDCAP AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Medicarb AB
Medicarb AB Pharmaceuticals: MajorHealth Technology Medicarb AB manufactures pharmaceutical products. It develops pharmaceuticals from biologically active carbohydrates and improves the performance of blood and tissue contacting medical devices with biocompatible coatings. The company was founded in 1983 and is headquartered in Bromma, Sweden. | Health Technology |
Mölnlycke Health Care Group AB
Mölnlycke Health Care Group AB Medical SpecialtiesHealth Technology Mölnlycke Health Care manufactures and markets single-use surgical and wound care products. The firm's surgical division offers surgical solutions through a range of single-use products that help minimize the risk of infections for patients, protect healthcare workers and increase the efficiency in the operating room. Its brands include: BARRIER, Biogel and HiBi. The company is headquartered in Gothenburg, Sweden. | Health Technology |
Celltrix AB
Celltrix AB Medical SpecialtiesHealth Technology Celltrix AB manufactures medical devices. It develops novel and injectable dermal filler for reconstructive cosmetic surgery, based on microbeads of cross-linked gelatine. The company was founded in December 2003 by Kjell Gösta Conny Nilsson and is headquartered in Malmö, Sweden. | Health Technology |
Karocell Tissue Engineering AB
Karocell Tissue Engineering AB Miscellaneous Commercial ServicesCommercial Services Karocell Tissue Engineering AB was started in 2001 based on research from the Karolinska Institute since the end of the 1980's. It was founded by Professor Gunnar Kratz and Doctor Anders Boman to further develop their ideas within culturing of cells and tissue engineering. Tissue engineering, which is one of the fastest growing areas in medicine today, applies the principles of biology and engineering to the development of functional substitutes for damaged tissues. The objective is to have the engineered tissue to become integrated with the patient's own tissue. This can be achieved either by culturing cells in vitro for transplantation as an auto transplant or by guiding cells in vivo to regeneration. Karocell's core operations are; production of autologous cells, and management of a skin bank and a cell bank. | Commercial Services |
